Opioid and adjuvant analgesics: Compared and contrasted

American Journal of Hospice and Palliative Medicine

Volumn 28, Issue 5, 2011, Pages 378-383

  Khan, Mohammed Ilyas Ahmed ^a   Walsh, Declan ^a,b   Brito Dellan, Norman ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b The Harry R Horvitz Chair in Palliative Medicine   (United States)

Author keywords

adjuvant analgesics; cancer pain; opioids; symptoms

Indexed keywords

ANALGESIC AGENT; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; HOSPITALIZATION; HUMAN; METHODOLOGY; NEOPLASM; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY;

ADJUVANTS, PHARMACEUTIC; ANALGESICS; ANALGESICS, OPIOID; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; NARCOTICS; NEOPLASMS; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE; SEVERITY OF ILLNESS INDEX;

EID: 80051608976     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909111410298     Document Type: Article

References (18)

1. Donnelly S., Davis MP, Walsh D., Naughton M. Morphine in cancer pain management: a practical guide. Support Care Cancer. 2002;10(1):13-35.
2. Ripamonti C., Zecca E., De Conno F. Pharmacologic treatment of cancer pain: alternative routes of opioid administration. Tumori. 1998;84(3):289-300.
3. Sloan P., Melzack R. Long-term patterns of morphine dosage and pain intensity among cancer patients. Hosp J. 1999; 14(2):35-47.
4. Ventafridda V., Tamburini M., Caraceni A.,et al.A validation study of the WHO method for cancer pain relief. Cancer. 1987; 59(4):850-856.
5. Ross FB, Smith MT The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain. 1997;73(2):151-157.
6. Ebert B., Andersen S., Krogsgaard-Larsen P. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett. 1995;187(3):165-168.
7. Selley DE, Breivogel CS, Childers SR Opioid inhibition of adenylyl cyclase in membranes from pertussis toxin-treated NG108-15 cells. J Recept Signal Transduct Res. 1998;18(1): 25-49.
8. Mercadante S., Casuccio A., Agnello A.,et al.Morphine versus methadone in the pain treatment of advanced-cancer patients followed up at home. J Clin Oncol. 1998;16(11):3656-3661.
9. Gear RW, Miaskowski C., Heller PH,et al.Benzodiazepine mediated antagonism of opioid analgesia. Pain. 1997;71(1): 25-29.
10. Varenna M., Zucchi F., Ghiringhelli D.,et al.Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol. 2000;27(6):1477-1483.
11. Cortet B., Flipo RM, Coquerelle P.,et al.Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate. Clin Rheumatol. 1997;6(1):51-56.
12. Eisenach JC, DuPen S., Dubois M.,et al.Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain. 1995;61(3):391-399.
13. Fromm GH Trigeminal neuralgia and related disorders. Neurol Clin. 1989;7(2):305-319.
14. Wallace MS, Dyck JB, Rossi SS,et al.Computer-controlled lidocaine infusion for the evaluation of neuropathic pain after peripheral nerve injury. Pain. 1996;66(1):69-77.
15. Malmberg AB, Yaksh TL Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 1992;263(1):136-146.
16. Martin TJ, Eisenach JC Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther. 2001; 299(3):811-817.
17. Zeppetella G., Paul J., Ribeiro MD Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage. 2003;25(6):555-558.
18. Mercadante S., Fulfaro F., Casuccio A.,et al.Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manage. 1999;18(5):347-352.